Areas

Research areas

Non-communicable diseases

At the Clalit Research Institute, we monitor the progression of chronic illnesses, identify members at-risk for developing chronic illness, and target innovative and personalized treatments for their prevention and management.

Diabetes Diabetes

The Clalit Research Institute has developed accurate algorithms to identify members at risk for diabetes and patients with diabetes.

CRC Colorectal Cancer

A data-mining-based method to identify members at highest risk for developing colorectal cancer in order to target intensive outreach for screening.

CC-MAP Multimorbidity

A large-scale intervention study evaluating an innovative primary care physician-nurse team-based care management program for patients with multimorbidities.

AF graph Atrial Fibrillation

An EHR-data-driven study to identify atrial fibrillation early and prevent its complications in the general population.

Asthma Asthma

A five-year study found that children with asthma are 2.5 times more likely to experience an exacerbation in September compared to the prior summer months.

Communicable diseases

We track rates of infectious disease to conduct studies on real-world effectiveness, comparative effectiveness, disease burden, and to be able to identify opportunities for screening and prevention.

Credit: FreeImages.com Hepatitis C Virus

A real-world treatment effectiveness evaluation and observed incidence and prevalence of HCV in a general population to inform future screening efforts and treatment options.

Pneumococcal vaccine targeting Pneumococcal vaccine

A real-world effectiveness study of the pneumococcal vaccine (PPSV23) and assessment of various vaccine strategies including a population-customized risk model.

 Influenza Vaccine

Three real-world effectiveness studies are taking place with the US CDC, to evaluate the effectiveness of the influenza vaccine in three higher risk populations.

Health Services Evaluation

With an emphasis on improving the quality of care, our health services evaluations focus on outcomes research at the population level, ranging from care intervention assessments, medication use and hospitalisations to vaccination administration and screening policies.

Readmission Hospital readmissions

The development and implementation of an organization-wide strategy to prevent 30-day hospital readmissions.

Health disparities graph Health disparities

The implementation and evaluation of a quality improvement-based targeted disparity reduction strategy among disadvantaged populations.